MEDIWARE INFORMATION SYSTEMS INC
NT 10-Q, 1999-11-15
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: ALLIED HEALTHCARE PRODUCTS INC, 10-Q, 1999-11-15
Next: OSTEOTECH INC, 10-Q, 1999-11-15



                     U.S. SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING



Form 10-K        Form 20-F       Form 11-K [X]       Form 10-Q       Form N-SAR

For Period Ended:                                             September 30, 1999
- --------------------------------------------------------------------------------

Transition Report on Form 10-K                    Transition Report on Form 10-Q
Transition Report on Form 20-F                    Transition Report on Form 11-K
Transition Report on N-SAR

For the Transition Period Ended:
- --------------------------------------------------------------------------------

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:


- --------------------------------------------------------------------------------
Part I -- Registrant Information
- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

Full Name of Registrant                       Mediware Information Systems, Inc.


Former Name if Applicable:


1121 Old Walt Whitman Road
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

Melville, New York 11747-3005
- --------------------------------------------------------------------------------
(City, State and Zip Code)

- --------------------------------------------------------------------------------
PART II -- Rules 12b 25(b) and (c)
- --------------------------------------------------------------------------------

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check appropriate box)

- --------------------------------------------------------------------------------

(a)  The reasons  described in reasonable  detail in Part III of this form could
     not be eliminated without unreasonable effort or expense;

- --------------------------------------------------------------------------------

(b)  The subject annual report,  semi-annual  report,  transition report on Form
     10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
     before the 15th  calendar day  following  the  prescribed  due date; or the
     subject  quarterly  report or  transition  report on Form 10-Q,  or portion
     thereof  will be filed on or before the fifth  calendar day  following  the
     prescribed due date; and

- --------------------------------------------------------------------------------

(c)  The accountant's  statement or other exhibit required by Rule 12b-25(c) has
     been attached if applicable.

- --------------------------------------------------------------------------------
Part III -- Narrative
- --------------------------------------------------------------------------------

State below in  reasonable  detail the reasons why  10-KSB,  20-F,  11-K,  10-Q,
N-SAR, or the transition report or portion thereof could not be filed within the
prescribed period.

The Registrant is unable to file its Quarterly Report on Form 10-Q for the first
quarter ended  September 30, 1999 for the following  reasons:  The  Registrant's
financial  statements  for the quarter  ended  September  30, 1999 have not been
completed due to the conversion of some of the  registrant's  subsidiaries  to a
new accounting system computer package.

<PAGE>

- --------------------------------------------------------------------------------
PART IV -- Other Information
- --------------------------------------------------------------------------------

(1)  Name and telephone number of person to contact in regard to notification

- --------------------------------------------------------------------------------

         John Esposito                 913                       307-1000
 ---------------------------        -----------           ----------------------
            (Name)                  (Area Code)             (Telephone Number)

- --------------------------------------------------------------------------------

(2)  Have all other periodic  reports  required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter  period that the
     registrant was required to file such report(s) been filed? If the answer is
     no, identify report(s).

                              _X_  Yes     ___ No

- --------------------------------------------------------------------------------

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding  period for the last fiscal year will be reflected by the
     earnings  statements  to be  included  in the  subject  report  or  portion
     thereof?

                              ___  Yes      _X_ No

- --------------------------------------------------------------------------------

If so: attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

- --------------------------------------------------------------------------------

Mediware Information Systems, Inc.
(Name of Registrant as specified in charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.


Date: November 14, 1999                    By       /s/ Kerry Robison
                                                    ----------------------------
                                                    Kerry Robison
                                                    Chief Financial Officer




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission